APOA1 and autoimmune disease: In addition, in patients with autoimmune diseases, as systemic lupus erythematosus and rheumatoid arthritis, the presence of autoantibodies against apoA-I has been described and associated with an impairment of HDL function, likely contributing to the increased CV risk of these patients [76].